Rentokil Initial PLC (LSE:RTO)’s revenues were up 4.9% in the first quarter, or 3.1% on an organic basis when stripping out the impact of acquisitions including HiCare in India.
North American growth “stabilised” in the quarter, the FTSE 100-listed group said, with organic revenues up 1.5% in the region. LATAM, the group’s second-largest market, saw organic revenue growth of 4.1%.
Chief executive Andy Ransom called it “a positive overall start to 2024”.
“The group has performed well and our RIGHT WAY 2 plan has delivered a stabilising performance in North America.
“With the key trading period for the business ahead of us, we remain confident in delivering on our guidance of 2-4% organic revenue growth in the region.”
The market appeared underwhelmed by the results, with shares dipping 3.3% in opening trades.